Clinical implications of immune-mediated diseases in children with Down syndrome

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Children with Down syndrome exhibit altered innate and adaptive immunity, increasing susceptibility to infections, autoimmune disorders, and certain cancers.
• While advancements in congenital heart disease care have improved survival, immune-mediated conditions remain a significant factor limiting life expectancy.

Purpose of the Study:

• To review the multifaceted impact of immune system alterations in Down syndrome.
• To discuss the implications for infection rates, autoimmune and autoinflammatory conditions.
• To highlight strategies for prevention and management of immune-related morbidities.

Main Methods:

• Literature review of immunological, clinical, and epidemiological studies concerning Down syndrome.
• Analysis of the interplay between genetic factors, immune dysfunction, and associated health complications.
• Synthesis of current evidence on preventative and therapeutic approaches.

Main Results:

• Down syndrome is associated with significant immunological changes affecting both innate and adaptive responses.
• Increased prevalence of infections, autoimmune diseases (celiac, type 1 diabetes, thyroid), and autoinflammatory conditions is observed.
• Anatomical and physiological variations further exacerbate infection risk, particularly respiratory tract infections.

Conclusions:

• A multifactorial approach, including immunizations and potential surgical interventions, is crucial for preventing infections.
• Screening for autoimmune diseases is essential, and immunosuppression requires careful consideration.
• Further research into optimal screening and immune modulation is needed to enhance quality of life and reduce mortality.